Ron Gillis
About Ron Gillis
Ron Gillis is the President and CEO of Control Techniques Int'l, based in Clermont, FL, with over four decades of experience in consulting for engineering and construction in the petroleum, petrochemical, and pharmaceutical industries.
Company
Ron Gillis is currently the President and CEO of Control Techniques Int'l, which he founded in 1978. The company is based in Clermont, Florida, and specializes in consulting for engineering and construction. Control Techniques Int'l primarily serves the petroleum, petrochemical, and pharmaceutical industries. Gillis has been leading the company since its inception, guiding it through various phases of growth and development over the past four decades.
Professional Title
Ron Gillis holds the titles of President and CEO at Control Techniques Int'l. Prior to founding his own company, he worked as a Vice President at Jacobs Engineering, Inc. from 1974 to 1979. His work experience spans over 45 years, during which he has gained extensive expertise in the engineering and construction sectors, particularly within the petroleum and petrochemical industries.
Education and Expertise
Ron Gillis has a diverse educational background. He earned a Bachelor of Science degree in Economics from Boston College and is also a guest lecturer at Harvard Business School, Harvard, M.I.T., Virginia Polytechnic Institute, University of Florida, and AACE. Gillis holds an MBA from PMC University. His educational pursuits have equipped him with a strong foundation in economics and management, contributing to his extensive experience in consulting for engineering and construction projects.
Background in Engineering and Construction
Ron Gillis has over four decades of experience in the engineering and construction sectors. His career began at Jacobs Engineering, Inc., where he served as Vice President from 1974 to 1979 in Houston, Texas. He then founded Control Techniques Int'l, where he has applied his extensive expertise in consulting for the petroleum, petrochemical, and pharmaceutical industries. His long-standing career boasts numerous accomplishments and a deep understanding of the industry's nuances.